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Abstract objective To assess the performance of RDTs against nested polymerase chain reaction (nPCR) for
the diagnosis of malaria in public health facilities in north-western Ethiopia.
methods Cross-sectional study at public health facilities in North Gondar, Ethiopia, of 359 febrile
patients with signs and symptoms consistent with malaria. Finger prick blood samples were collected
for testing in a P. falciparum/pan-malaria RDTs and for molecular analysis. Sensitivity, specificity
and predictive values were determined for the RDTs using nPCR as reference diagnostic method.
Kappa value was determined to demonstrate the consistency of the results between the diagnostic
tools.
results By RDTs, 22.28% (80/359) of patients tested positive for malaria, and by nPCR, 27.02%
(97/359) did. In nPCR, 1.67% (6/359) and 0.28% (1/359) samples were positive for P. ovale and
P. malariae, which had almost all tested negative in the RDTs. The sensitivity, specificity, positive
and negative predictive values of RDTs for the diagnosis of malaria were 62.9%, 92.7%, 76.3% and
87.1%, respectively, with 0.589 measurement agreement between RDTs and nPCR. The sensitivity
and specificity of RDTs for P. falciparum identification only were 70.8% and 95.2%, and 65.2% and
93.1% for P. vivax.
conclusion Although RDTs are commonly used at health posts in resource-limited environments,
their sensitivity and specificity for the detection and species identification of Plasmodium parasites
were poor compared to nPCR, suggesting caution in interpreting RDTs results. Particularly, in the
light of expanded efforts to eliminate malaria in the country, more sensitive diagnostic procedures
will be needed.
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Background
Although malaria caused by Plasmodium falciparum
remains the predominant species in Ethiopia, non-falci-
parum malaria is gaining importance. Close to one-third of
malaria cases in Ethiopia are caused by P. vivax. P. ovale
and P. malariae have only recently been identified as con-
tributing a significant proportion of malaria cases [1, 2].
Malaria threatens the lives of 40% of the world’s
population [3]. Each year, there are estimated 350–
500 million clinical cases, with about 90% of these
occurring in sub-Saharan Africa [3–5]. Malaria is a lead-
ing communicable disease in Ethiopia: an estimated
57.3 million (68%) of the 84.3 million population live in
areas at risk of malaria. The Federal Ministry of Health
(FMOH) estimates that there are 5–10 million clinical
malaria cases each year. In 2009/2010 health and health
indicators report, 1581 malaria deaths were reported in
Ethiopia [6].
In Ethiopia, the main species P. falciparum and
P. vivax account for 60% and 40% of malaria cases,
respectively [7], but only P. falciparum commonly*These authors contributed equally to this work.
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causes severe disease in which the case fatality rate is
about 10% in hospitalised adults and up to 33% in
children under 12 years [8]. In addition to the health
impact, malaria has a significant impediment to the
socio-economic development of the country. Fertile low-
lands and major river valleys have not been populated
and developed largely due to the high malaria burden in
these areas.
In Ethiopia, early diagnosis and prompt treatment are
the main strategies in malaria prevention and control and
to reduce morbidity and prevent mortality [9]. However,
clinical diagnosis and empirical treatment have been the
mainstay of malaria management in areas where labora-
tory facilities are not available. However, clinical diagno-
sis is notoriously unreliable and leads to overdiagnosis
and overtreatment [10].
Although frequently not accessible in most peripheral
health facilities in the country, Giemsa microscopy
remains the gold standard for the laboratory diagnosis of
malaria. However, it is time-consuming, requires trained
personnel and needs careful preparation and application
of reagents [11]. As a result, rapid diagnostic tests
(RDTs) have been introduced for the diagnosis of malaria
in remote areas where there are no microscopy facilities.
However, poor and varying performances of RDTs have
been reported in Ethiopia [12]. Therefore, this study
aimed to assess the performance of RDTs as compared to
nested polymerase chain reaction (nPCR), the most sensi-
tive reference test, for the diagnosis of malaria at public
health facilities in North Gondar, Amhara Regional State,
Ethiopia.
Materials and methods
Setting and design
The study was conducted at Health Posts under Lamba
Health Center, Maksegnet Health Center and Kola Diba
Health Center in North Gondar, Amhara Regional State,
Ethiopia. The altitude at these sites ranges from 1750 to
2100 m above sea level. According to the Municipal
Health Bureau report, malaria is the most prevalent sea-
sonal disease in these areas.
A health centre-based cross-sectional study was con-
ducted from February to September 2014. Self-reporting
febrile patients, in the age ranging from 1 year to
81 years, with signs and symptoms consistent with
malaria attending either of the health posts were invited
to participate. Patients who had received antimalarial
drugs during the past 4 weeks prior to enrolment and
patients unwilling to give consent and/or a blood sample
were excluded from the study.
Study participants were recruited consecutively until
a total of 359 patients with signs and symptoms
consistent with malaria had been reached. Finger
prick blood samples were collected from every
participant and used to carry out RDT (CareStartTM
Pf/Pan) analysis. CareStartTM Pf/Pan is targeted to
detect P. falciparum histidine-rich protein-2 and plas-
modial lactate dehydrogenase for the diagnosis of
P. falciparum and other Plasmodium species, respec-
tively.
Laboratory procedures
Two drops of blood from each participant were collected
and transferred on filter paper (Whatman #903, GE
Healthcare) labelled with the participant’s study code
and date. Each filter paper was dried individually to
avoid any chance of contamination. The samples were
then stored in small sealable plastic bags with desiccant
and underwent molecular analysis at the laboratories of
the Medical University of Vienna (MUV), Vienna, Aus-
tria.
A modified Chelex-based DNA extraction method
using the InstaGene Whole Blood Kit (Bio-Rad Labora-
tories, Hercules, CA, USA) was used for the extraction
and purification of Plasmodium DNA from the blood
spots on filter paper. Parasite detection and species clas-
sification by nested PCR assay were performed for all
samples as described previously [13, 14]. The individual
interpreting the nPCR results was blinded to the results
of RDTs.
Data analysis
Sensitivity, specificity and predictive values were deter-
mined using SISA online statistical software [15]. The
kappa coefficient (Cohen’s kappa coefficient as a measure
of agreement for qualitative items) was determined to
confirm the consistency of the results between the diag-
nostic tools.
Ethics
The study protocol was reviewed and approved by the
Institutional Review Board of University of Gondar prior
to the study. Informed consent and assent were obtained
from all participants and/or their legal representatives
after being translated and read in the vernacular language
that the patients or the caretakers understood. Patients
who tested positive for malaria by RDTs received imme-
diate treatment according to the Ethiopian national treat-
ment guidelines.
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Results
Comparison of RDTs and nPCRs
Among the study participants, 22.28% (80/359) patients
tested positive for malaria by RDTs of whom 12.53%
(45/359), 5.85% (21/359) and 3.9% (12/359) were diag-
nosed as P. falciparum, P. vivax and mixed infection of
P. falciparum and P. vivax, respectively. By nPCR,
27.02% (97/359) patients were malaria positive. Among
RDT-negative samples, 12.9% (36/279) samples turned
malaria positive by nPCR. In nPCR, the rate of mixed
infection was 4.46% (16/359). The rates of P. ovalae and
P. malariae infections were 1.67% (6/359) and 0.28%
(1/359), respectively. Only one case of P. ovalae was
reported as mixed infection of P. falciparum and P. vi-
vax, while none of the P. ovalae and P. malariae infec-
tions were identified by RDTs (Table 1).
Diagnostic accuracy of RDTs compared to nested PCR
for the diagnosis of malaria
Malaria rapid diagnostic tests had a sensitivity and speci-
ficity of 62.9% (95% CI: 50.6–75.1) and 92.7% (95%
CI: 88.7–96.8), respectively, compared to the reference
method, nPCR. Its corresponding positive and negative
predictive values were 76.3% (95% CI: 64.4–88.1) and
87.1 (95% CI: 82.1–92.1). Overall, there was a moderate
measurement agreement of test results between RDTs
and nPCR (Kappa = 0.589).
RDTs had a sensitivity and specificity of 70.8% (95%
CI: 56.7–84.9) and 95.2% (95% CI: 92.0–98.5) for the
diagnosis and identification of P. falciparum, respectively.
The corresponding sensitivity and specificity for the diag-
nosis and identification of P. vivax were 65.2% (95%
CI: 40.4–90.0) and 93.1% (95% CI: 89.4–96.8), respec-
tively.
Discussion
Early, prompt and particularly accurate malaria diagnosis
down to species level even in remote areas is needed to
provide prompt treatment and optimal case management
of malaria [16, 17]. Standard diagnostic methods, such as
Giemsa microscopy and RDTs, have become commonly
available at most health facilities, even in resource-limited
environments. However, both techniques have inherent
limitations and show relatively poor performance with
low parasite densities [11, 18–20]. The sensitivity of most
RDTs used in routine diagnosis is strongly dependent on
the parasite density and on the parasite species. The
threshold of parasite density reliability giving positive
results is also largely dependent on environmental factors,
the brand of the RDTs, the targeted antigens, and a num-
ber of host factors. In previous publications the detection
limits of RDTs has therefore been estimated at up to 200
parasites/ll of whole blood [21]. Non-falciparum malaria
remains a major challenge for most RDTs with sensitivi-
ties reaching only non-satisfactory levels. In addition,
many RDTs are not designed to adequately identify para-
site species other than P. falciparum.
The combination of antibodies detecting P. falciparum
antigens with antibodies detecting so called pan-malaria
antigens is a common, economical, and to a certain
extent highly valuable approach to designing RDTs.
However, this does not allow for the identification of
mixed infections and leaves non-falciparum malaria noto-
riously underdetected.
While non-falciparum malaria (mostly P. ovale and
P. malariae) is not very common in most African coun-
tries, Ethiopia reports one of the highest P. vivax burdens
in the world. P. malariae infections, however, seem to be
uncommon in the region. In fact this is the first report of
a confirmed P. malariae infection in this part of Ethiopia.
There also seems to be a clear trend towards a relatively
higher prevalence of non-falciparum due to a strong focus
on falciparum malaria in the current malaria control pro-
gramme, as seen previously, for example in South-East
Asia [22–24]. Nevertheless, the elimination of P. falci-
parum is a goal in itself, and would be a major achieve-
ment even if that of the other species would take much
longer. In this setting, the accurate diagnosis of non-falci-
parum malaria, preferably down to species level is there-
fore of utmost importance. This particularly applies to
Table 1 Comparison of RDTs and nested polymerase chain
reaction for the diagnosis and species identification of malaria
parasites, North Gondar, Amhara, Ethiopia, 2014
RDT (n) nPCR (n)
P. falciparum (45) P. falciparum (34); negative (11)
P. vivax (21) P. falciparum (2); P. vivax (10); positive
of genus Plasmodium (1); negative (8)
Mixed P. falciparum
and P. vivax (14)
P. falciparum (8); P. vivax (1); mixed
infection of P. falciparum and vivax (4);
P. ovalae (1)
Negative (279) P. falciparum (17); P. vivax (6); P. ovalae
(5); mixed infection of P. falciparum,
vivax and malariae (1); mixed infection
of P. falciparum and vivax (1); positive
for genus Plasmodium (6); negative
(243)
n, number of blood samples tested; nPCR, nested polymerase
chain reaction; RDTs, rapid diagnostic malaria tests.
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elimination settings in which non-falciparum malaria is
likely to play an important role due to the inherent chal-
lenges associated with eliminating relapsing malaria.
The present study adds relevant information regarding
the performance of currently used malaria RDTs in the
study area. RDTs showed a sensitivity of only 62.9%
and specificity of 92.7% regardless of Plasmodium spe-
cies when using nPCR as a reference method. In practice,
this means that more than 10% of all patient samples
would have been missed as being malaria positive. The
utilisation of Plasmodium genus and species-specific
markers makes nested PCR an ideal confirmatory test for
malaria diagnosis as it also allows for the detection of
low density infections and even more importantly of
mixed infections, which could not be identified by the
RDTs used in this study [13].
A similarly poor performance of malaria RDTs has
previously been reported from Gabon, Nigeria and
China–Myanmar [25–27]. A study from Zambia reported
that community health workers read faint positive and
invalid results of RDTs as negative suggesting that sub-
jective interpretation may contribute to poor performance
[28]. An earlier study from Angola suggested that perfor-
mance may also be related to the age of the patients with
malaria [29]. In the current study, 57.4% of the study
participants were 18 years and older. Accordingly, the
sensitivity of RDTs in study participants under 18 years
(72.9%) was higher than older ages (50.0%). The fact
that previous studies in Ethiopia and Burkina Faso
reported a relatively good performance of malaria RDTs
compared to Giemsa microscopy [30, 31] may have been
influenced by the inherent limitations of Giemsa micro-
scopy rather than good performance of RDTs [22].
In the current study, the RDTs consistently showed
better performance in P. falciparum than in P. vivax
(sensitivity 70.8% vs. 65.2% and specificity 95.2% vs.
93.1%). Similar results have been reported previously,
for example from Belgium and the China–Myanmar bor-
der area. Throughout most studies the key factors con-
tributing to the performance of RDTs are parasite density
and Plasmodium species.
A factor strongly influencing the performance of
HRP2-based RDTs in certain regions of the world seems
to be the genetic variability of the PfHRP2 gene which
results in P. falciparum infections not being detected in
spite of relatively high parasite densities [32]. This has
previously been reported from a number of countries in
Latin America [33, 34]. In how far this could influence
RDTs results in Ethiopia remains to be seen.
The relatively poor performance of RDTs in our study
underlines the urgent need for new diagnostic tests that
are highly sensitive and specific but also economical and
field deployable. Nested PCR, which was used as the ref-
erence test in this study, may provide adequate perfor-
mance but is clearly not suited for use in resource-limited
environments. Loop-mediated isothermal amplification
(LAMP), a relatively recent development that consider-
ably simplifies molecular analysis, may be a major step
towards making molecular techniques available in such
settings. In the meantime, the performance of RDTs
could profit from improved training for healthcare work-
ers and from optimising integrated diagnostic approaches
with the ultimate goal of supporting malaria elimination
programmes in Ethiopia [35–37].
One limitation of this study is that malaria microscopy
was not performed and parasite density therefore not
reported.
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